d December5, 2025. Accessed December 2025.https://clinicaltrials.gov/study/NCT06671483?cond=Psoriatic%20Arthritis&term=tak-279&rank=2

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines. ClinicalTrials.gov Identifier: NCT06671496. Updated December5, 2025. Accessed December 2025.https://clinicaltrials.gov/study/NCT06671496?cond=Psoriatic%20Arthritis&term=tak-%20279&rank=1.

https://clinicaltrials.gov/study/NCT06973291A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease. ClinicalTrials.gov Identifier: NCT06233461. Updated December 17, 2025. Accessed: December 2025.https://clinicaltrials.gov/study/NCT06233461.

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis. ClinicalTri
=*=*=*=*=*=
当前为第15/20页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页